Top

BMC Cancer

Published in:

01-12-2020 | Brachytherapy | Correction

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas

Authors: Congxiao Wang, Shifeng Liu, Lijing Peng, Kaixian Zhang, Wei Li, Hao Zhang, Ying Luan, Peishun Li, Xiaokun Hu

Published in: BMC Cancer | Issue 1/2020

Excerpt

Correction to: BMC Cancer 20, 591 (2020) …

Wang C, Liu S, Peng L, et al. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas. BMC Cancer. 2020;20:591. https://doi.org/10.1186/s12885-020-07086-8.CrossRefPubMedPubMedCentral

Title: Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
Authors: Congxiao Wang
Shifeng Liu
Lijing Peng
Kaixian Zhang
Wei Li
Hao Zhang
Ying Luan
Peishun Li
Xiaokun Hu
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Brachytherapy
Glioma
Glioma
Glioma
Published in: BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-020-07246-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up

Longitudinal changes in sports activity from pre-diagnosis to first five years post-diagnosis: a prospective Chinese breast cancer cohort study

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

Parental occupational exposure to pesticides and risk of childhood cancer in Switzerland: a census-based cohort study

miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9

Keynote webinar | Spotlight on antibody–drug conjugates in cancer